Nasdaq · Healthcare
CVRx, Inc. (CVRX)
As-reported financials and recent SEC filings for CVRx, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$56.7M
Net income
$-53.3M
Net margin
-94.1%
Diluted EPS
$-2.04
ROE
-135.6%
P/E (TTM)
—
Market cap
—
Debt / equity
1.3×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $56.7M | $51.3M | $39.3M | $22.5M | $13.0M |
| Gross profit | $48.3M | $43.0M | $33.0M | $17.5M | $9.4M |
| Operating income | $-51.3M | $-59.5M | $-43.1M | $-42.5M | $-26.0M |
| Net income | $-53.3M | $-60.0M | $-41.2M | $-41.4M | $-43.1M |
| Diluted EPS | $-2.04 | $-2.65 | $-1.99 | $-2.02 | $-2.08 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-09
View on EDGAR →42026-06-03
View on EDGAR →42026-06-03
View on EDGAR →42026-06-03
View on EDGAR →42026-06-03
View on EDGAR →42026-06-03
View on EDGAR →42026-06-03
View on EDGAR →42026-06-03
View on EDGAR →Largest Healthcare peers
Go deeper on CVRX
Search CVRx, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.